Sublingual immunotherapy for adults

BlueCross BlueShield Association
Record ID 32003000768
Authors' objectives:

The Assessment seeks to determine whether sublingual immunotherapy (SLIT) improves health outcomes for patients with seasonal or perennial allergies, when compared with subcutaneous injections for allergen-specific immunotherapy (ASIT).

Authors' methods: Systematic review
Project Status: Completed
Year Published: 2003
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Administration, Sublingual
  • Hypersensitivity
  • Rhinitis, Allergic, Perennial
Organisation Name: BlueCross BlueShield Association
Contact Address: BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name:
Contact Email:
Copyright: BlueCross BlueShield Association (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.